India finally wakes up to drug-resistant TB
India has finally decided to start diagnosis and treatment of the deadly Multi Drug Resistant TB (MDR TB) in the country. Under the second phase of the Rs 1,156 crore Revised National TB Control
India has finally decided to start diagnosis and treatment of the deadly Multi Drug Resistant TB (MDR TB) in the country. Under the second phase of the Rs 1,156 crore Revised National TB Control